Ep40: Taking DTx to Market: Nate Beyor Gives Insights On Building Teams and Products
In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird’s eye view across BCG’s customer base.
In this episode, we cover:
- New company creation: large company spin-outs vs entrepreneurs
- What it takes to build a team that can take a digital therapeutic to market
- Why build rather than buy a new DTx
- Approaching medical pharma clients vs approaching smaller DTx companies
- Go to market strategy and value creation: Standalone vs Drug+
- Embedding clinical decision support into workflows
Guest Links and Resources:
- Connect with Nate Beyor on: LinkedIn
- Visit: www.bcg.com/
Host Links:
- Connect with Eugene Borukhovich: Twitter | LinkedIn
- Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
- Connect with YourCoach.health: Website | Twitter
- Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
- HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
